NO991569D0 - Liquid alendronate compounds - Google Patents

Liquid alendronate compounds

Info

Publication number: NO991569D0
Authority: NO; Norway
Prior art keywords: compounds; liquid; liquid alendronate; alendronate compounds; alendronate
Prior art date: 1996-10-04

Application number

NO991569A

Other languages

Norwegian (no)

Other versions

NO991569L (en

Inventor

Maneesh J Nerurkar

William H Hunke

Drazen Ostovic

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-04

Filing date

1999-03-30

Publication date

1999-03-30

1997-01-13 Priority claimed from GBGB9700541.7A external-priority patent/GB9700541D0/en

1999-03-30 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1999-03-30 Publication of NO991569D0 publication Critical patent/NO991569D0/en

1999-06-04 Publication of NO991569L publication Critical patent/NO991569L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO991569A 1996-10-04 1999-03-30 Liquid alendronate compounds NO991569L (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US2676596P	1996-10-04	1996-10-04
GBGB9700541.7A GB9700541D0 (en)	1997-01-13	1997-01-13	Liquid alendronate formulation
US3600297P	1997-01-22	1997-01-22
PCT/US1997/015740 WO1998014196A1 (en)	1996-10-04	1997-10-02	Liquid alendronate formulations

Publications (2)

Publication Number	Publication Date
NO991569D0 true NO991569D0 (en)	1999-03-30
NO991569L NO991569L (en)	1999-06-04

Family

ID=27268667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO991569A NO991569L (en)	1996-10-04	1999-03-30	Liquid alendronate compounds

Country Status (20)

Country	Link
EP (1)	EP1007054A4 (en)
JP (1)	JP2001501222A (en)
CN (1)	CN1238691A (en)
AU (1)	AU723357B2 (en)
BG (1)	BG103306A (en)
BR (1)	BR9712197A (en)
CA (1)	CA2267370A1 (en)
CZ (1)	CZ116999A3 (en)
EA (1)	EA001213B1 (en)
EE (1)	EE03669B1 (en)
HU (1)	HUP0000125A3 (en)
IL (1)	IL129127A0 (en)
IS (1)	IS5012A (en)
NO (1)	NO991569L (en)
NZ (1)	NZ334836A (en)
PL (1)	PL332496A1 (en)
SK (1)	SK42999A3 (en)
TR (1)	TR199900730T2 (en)
WO (1)	WO1998014196A1 (en)
YU (1)	YU17499A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002058708A1 (en)	2001-01-23	2002-08-01	Gador S.A.	Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
US7645460B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of risedronate
US20080287400A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of bisphosphonates
US20080286359A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
WO2007031785A2 (en) *	2005-09-16	2007-03-22	Selamine Ltd	Bisphosphonate formulation
US7473684B2 (en)	2005-09-16	2009-01-06	Selamine Limited	Bisphosphonate formulation
JP2010043119A (en) *	2009-10-16	2010-02-25	Gador Sa	Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof
US8568747B1 (en)	2012-10-05	2013-10-29	Silvergate Pharmaceuticals, Inc.	Enalapril compositions
US9463183B1 (en)	2015-10-30	2016-10-11	Silvergate Pharmaceuticals, Inc.	Lisinopril formulations
US9669008B1 (en)	2016-03-18	2017-06-06	Silvergate Pharmaceuticals, Inc.	Enalapril formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4206209A (en) *	1978-11-02	1980-06-03	Kracauer Paul	Sublingual aspirin tablet
IT1201087B (en) *	1982-04-15	1989-01-27	Gentili Ist Spa	PHARMACOLOGICALLY ACTIVE BIPPHOSPHONES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
US4922007A (en) *	1989-06-09	1990-05-01	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) *	1990-06-20	1991-05-28	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5270365A (en) *	1991-12-17	1993-12-14	Merck & Co., Inc.	Prevention and treatment of periodontal disease with alendronate
US5358941A (en) *	1992-12-02	1994-10-25	Merck & Co., Inc.	Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (en) *	1993-04-05	1995-06-30	Sanofi Elf	USE OF BISPHOSPHONIC ACID DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR PROMOTING BONE REPAIR.
US5510517A (en) *	1993-08-25	1996-04-23	Merck & Co., Inc.	Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5462932A (en) *	1994-05-17	1995-10-31	Merck & Co., Inc.	Oral liquid alendronate formulations
US5780455A (en) *	1994-08-24	1998-07-14	Merck & Co., Inc.	Intravenous alendronate formulations
US5616571A (en) *	1995-06-06	1997-04-01	Merck & Co., Inc.	Bisphosphonates prevent bone loss associated with immunosuppressive therapy

1997
- 1997-10-02 IL IL12912797A patent/IL129127A0/en unknown
- 1997-10-02 BR BR9712197-5A patent/BR9712197A/en unknown
- 1997-10-02 EP EP97945195A patent/EP1007054A4/en not_active Withdrawn
- 1997-10-02 EA EA199900352A patent/EA001213B1/en not_active IP Right Cessation
- 1997-10-02 NZ NZ334836A patent/NZ334836A/en unknown
- 1997-10-02 PL PL97332496A patent/PL332496A1/en unknown
- 1997-10-02 SK SK429-99A patent/SK42999A3/en unknown
- 1997-10-02 HU HU0000125A patent/HUP0000125A3/en unknown
- 1997-10-02 AU AU46448/97A patent/AU723357B2/en not_active Ceased
- 1997-10-02 CZ CZ991169A patent/CZ116999A3/en unknown
- 1997-10-02 CA CA002267370A patent/CA2267370A1/en not_active Abandoned
- 1997-10-02 CN CN97180165A patent/CN1238691A/en active Pending
- 1997-10-02 JP JP10516541A patent/JP2001501222A/en active Pending
- 1997-10-02 TR TR1999/00730T patent/TR199900730T2/en unknown
- 1997-10-02 EE EEP199900113A patent/EE03669B1/en not_active IP Right Cessation
- 1997-10-02 WO PCT/US1997/015740 patent/WO1998014196A1/en not_active Ceased
1999
- 1999-03-26 IS IS5012A patent/IS5012A/en unknown
- 1999-03-30 NO NO991569A patent/NO991569L/en not_active Application Discontinuation
- 1999-03-31 YU YU17499A patent/YU17499A/en unknown
- 1999-04-02 BG BG103306A patent/BG103306A/en unknown

Also Published As

Publication number	Publication date
EA001213B1 (en)	2000-12-25
NZ334836A (en)	2000-11-24
AU4644897A (en)	1998-04-24
EP1007054A1 (en)	2000-06-14
CZ116999A3 (en)	1999-09-15
IS5012A (en)	1999-03-26
WO1998014196A1 (en)	1998-04-09
HUP0000125A2 (en)	2000-06-28
CN1238691A (en)	1999-12-15
YU17499A (en)	1999-11-22
TR199900730T2 (en)	1999-07-21
JP2001501222A (en)	2001-01-30
PL332496A1 (en)	1999-09-13
IL129127A0 (en)	2000-02-17
HUP0000125A3 (en)	2001-04-28
SK42999A3 (en)	2000-01-18
EA199900352A1 (en)	1999-08-26
BG103306A (en)	2000-01-31
EE03669B1 (en)	2002-04-15
NO991569L (en)	1999-06-04
AU723357B2 (en)	2000-08-24
BR9712197A (en)	1999-08-31
CA2267370A1 (en)	1998-04-09
EE9900113A (en)	1999-10-15
EP1007054A4 (en)	2000-07-19

Publication	Publication Date	Title
ID19609A (en)	1998-07-23	HETEROSICLIC COMPOUNDS
ID19403A (en)	1998-07-09	HETEROSICLIC COMPOUNDS
ID16152A (en)	1997-09-04	TRIARIL COMPOUNDS
PT860428E (en)	2005-04-29	PYRIMIDION COMPOUNDS
IS5479A (en)	2000-05-03	compounds
IS5478A (en)	2000-05-03	compounds
IS5477A (en)	2000-05-03	compounds
ID15904A (en)	1997-08-14	TIOFENOPIRIMIDINE COMPOUNDS
ID22850A (en)	1999-12-09	PIRAZINA COMPOUNDS
DK0777671T3 (en)	2000-07-24	Spiro-azabicyclic compounds
NO994877D0 (en)	1999-10-07	Calcilitic compounds
BR9710352A (en)	1999-08-17	Pyridylpyrrole compounds
ID20323A (en)	1998-11-26	TRIAZINILAMINOSTILBENA COMPOUNDS
ID18685A (en)	1998-04-30	SUBSTITUTED TRISICLIC COMPOUNDS
DE69716924D1 (en)	2002-12-12	Phosphonate-NUCLEOTIDE COMPOUNDS
IS5208A (en)	1999-10-05	compounds
BR9705635A (en)	1999-05-18	Compounds
NO991569D0 (en)	1999-03-30	Liquid alendronate compounds
DK0923594T3 (en)	2003-02-10	Bromothiacumicin compounds
FI970151A0 (en)	1997-01-14	Anti-virus-acting difluorostatone compounds
NO995404D0 (en)	1999-11-04	compounds
DE69709659D1 (en)	2002-02-21	HALOPROPARGYL-INCLUSION COMPOUNDS
NO996544D0 (en)	1999-12-29	compounds
ID20565A (en)	1999-01-14	GUIDELINES FOR LIQUID CONTINUOUSLY
ID22983A (en)	1999-12-23	FLUOROMETOXIMINO COMPOUNDS

Legal Events

Date	Code	Title	Description
2003-03-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application